|
Volumn 16, Issue 16, 2006, Pages 4366-4370
|
Analysis of complexes of inhibitors with Cryptosporidium hominis DHFR leads to a new trimethoprim derivative
|
Author keywords
Cryptosporidium hominis; Diaminopyrimidine; Dihydrofolate reductase; Docking
|
Indexed keywords
ANTIPROTOZOAL AGENT;
DIHYDROFOLATE REDUCTASE;
LIGAND;
PYRIMETHAMINE;
TRIMETHOPRIM;
TRIMETHOPRIM DERIVATIVE;
ACCURACY;
ARTICLE;
COMPUTER MODEL;
CRYPTOSPORIDIUM;
CRYPTOSPORIDIUM HOMINIS;
DRUG ACTIVITY;
DRUG DESIGN;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
DRUG TARGETING;
ENZYME ACTIVE SITE;
ENZYME ANALYSIS;
ENZYME SUBSTRATE COMPLEX;
IC 50;
LIGAND BINDING;
SPECIES DIFFERENCE;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
BINDING SITES;
CHEMISTRY, PHARMACEUTICAL;
CRYPTOSPORIDIUM;
DRUG DESIGN;
INHIBITORY CONCENTRATION 50;
LIGANDS;
MODELS, CHEMICAL;
MODELS, MOLECULAR;
PROTEIN BINDING;
TETRAHYDROFOLATE DEHYDROGENASE;
TRIMETHOPRIM;
CRYPTOSPORIDIUM HOMINIS;
|
EID: 33745713221
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/j.bmcl.2006.05.047 Document Type: Article |
Times cited : (21)
|
References (15)
|